However, in cancer cells expressing oncogenic forms of KRAS, the balance between the phosphorylation-dephosphorylation states of MYC is shifted toward an increased phosphorylation at Ser 62, thus reducing the amount MYC that undergoes ubiquitination and degradation. This evidence concerns the gene MYC and cancer.